| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 02/09/2006 | WO2006013078A2 Method and kit for microbiologically identifying vitamins in substance mixtures |
| 02/09/2006 | WO2006013014A2 Diagnostics and therapeutics for diseases associated with prostate-specific membrane antigen-like protein (psmal) |
| 02/09/2006 | WO2006013013A2 Diagnostics and therapeutics for diseases associated with protective protein for beta-galactosidase (ppgb) |
| 02/09/2006 | WO2006013012A2 Diagnostics and therapeutics for diseases associated with napsin 1 (nap1) |
| 02/09/2006 | WO2006012949A1 Method of diagnosing lawsonia intracellularis |
| 02/09/2006 | WO2006012886A1 Device and method for isolating cells, bioparticles and/or molecules from liquids for use with animals, in biotechnology, (including biotechnological research) and medical diagnostics |
| 02/09/2006 | WO2006012884A1 Device and method for isolating cells, bioparticles and/or molecules from liquids designed to be used for the treatment of human diseases |
| 02/09/2006 | WO2005121797A3 Screening method using antibody heavy chains |
| 02/09/2006 | WO2005118885A3 Methods and apparatus for detection of viral infection |
| 02/09/2006 | WO2005113786A3 Diagnostics and therapeutics for diseases associated with chymase (cma1) |
| 02/09/2006 | WO2005111621A3 Molecular scaffolds for hiv-1 epitopes |
| 02/09/2006 | WO2005110479A3 Treatments for pancreatic cancer |
| 02/09/2006 | WO2005106489A3 Diagnostics and therapeutics for diseases associated with c-c chemokine receptor 5 (ccr5) |
| 02/09/2006 | WO2005106424A3 Method for testing the resistance to scratching of plastic surfaces |
| 02/09/2006 | WO2005103285A3 Systems and methods for indicating oxidation of consumer products |
| 02/09/2006 | WO2005101022A3 Diagnostics and therapeutics for diseases associated with vitamin d (1,25-dihydroxyvitamin d3) receptor 1 (vdr1) |
| 02/09/2006 | WO2005093425A3 Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 58 (gpr58) |
| 02/09/2006 | WO2005093423A3 Diagnostics and therapeutics for diseases associated with peroxisome proliferative activated receptor alpha (ppara) |
| 02/09/2006 | WO2005093091A3 Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 26 (gpr26) |
| 02/09/2006 | WO2005090993A3 Diagnostics and therapeutics for diseases associated with lung seven transmembrane receptor 1 (lustr1) |
| 02/09/2006 | WO2005085292A3 Method for detecting the activatable free form of psa and the use thereof for diagnosing benign pathologies of the prostate and adenocarcinoma of the prostate |
| 02/09/2006 | WO2005075982A3 Method for the rapid diagnosis of targets in human body fluids |
| 02/09/2006 | WO2005074646A3 Methods and systems for joint analysis or array cgh data and gene expression data |
| 02/09/2006 | WO2005074467A3 Matrix array nanobiosensor |
| 02/09/2006 | WO2005068663A3 Methods of using peroxisome proliferator-activated receptor alpha target genes |
| 02/09/2006 | WO2005059779A3 Indexing scheme for formulation workflows |
| 02/09/2006 | WO2005056041A3 METHODS OF INHIBITING APOPTOSIS USING LATENT TGFβ |
| 02/09/2006 | WO2005050223A3 Proteome epitope tags and methods of use thereof in protein modification analysis |
| 02/09/2006 | WO2004088274A3 Psychoactive compound associated markers and method of use thereof |
| 02/09/2006 | WO2004056983A3 Metalloprotease proteins |
| 02/09/2006 | WO2004050839A3 Fragmentation-based methods and systems for sequence variation detection and discovery |
| 02/09/2006 | WO2004028478A3 Functional mutations in respiratory syncytial virus |
| 02/09/2006 | WO2004023101A3 Methods of cardiovascular disease assessment in an individual |
| 02/09/2006 | WO2004009616A3 Ghrelin analogs |
| 02/09/2006 | WO2003090691A3 Method and compositions for identifying anti-hiv therapeutic compounds |
| 02/09/2006 | WO2002097110A3 TUMOR ENDOTHELIAL MARKER 7α MOLECULES AND USES THEREOF |
| 02/09/2006 | WO2002088316A3 G-protein coupled receptors |
| 02/09/2006 | US20060031944 Embryonic stem cells capable of differentiating into desired cell lines |
| 02/09/2006 | US20060031026 Method and system for extracting and visualizing secondary RNA structure elements from protein-RNA complexes |
| 02/09/2006 | US20060031025 Detection of feature boundary pixels during array scanning |
| 02/09/2006 | US20060031024 Method of optimizing parameter values in a process of producing a product |
| 02/09/2006 | US20060031023 Mass intensity profiling system and uses thereof |
| 02/09/2006 | US20060031022 Method of planning and performing stability studies |
| 02/09/2006 | US20060031021 In vitro predictive method |
| 02/09/2006 | US20060031020 Computational approach for constructing an analyte binding motif |
| 02/09/2006 | US20060031019 Methods and compositions for assessing partially saturated pixel signals |
| 02/09/2006 | US20060031018 System and method for processing and reporting biologically significant events |
| 02/09/2006 | US20060030787 Devices and methods for obtaining mammary fluid samples for evaluating breast diseases, including cancer |
| 02/09/2006 | US20060030761 Micro optical sensor device |
| 02/09/2006 | US20060030699 Reaction product of thioctic acid and tris(aminoanilinocarbonylalkyl)methylaminocarbonylalkylamine or N,N-bis{N,N-bis(aminobenzoylaminoalkyl)aminocarbonylalkyl}aminoalkanoamide; reaction product with an oligosaccharide; immobilized on support to form sensor chip used for surface plasmon resonance |
| 02/09/2006 | US20060030597 Method of inhibiting angiogenesis |
| 02/09/2006 | US20060030553 Cell adhesion inhibitors |
| 02/09/2006 | US20060030530 Methods of screening for compounds that modulate the LSR-leptin interaction and their use in the prevention and treatment of obesity-related diseases |
| 02/09/2006 | US20060030524 Treatment of systemic lupus erythematosus by down-regulating the autoimmune response to autoantigens |
| 02/09/2006 | US20060030523 Binding to LRP5 or LRP6 receptor; promoting growth with DAN family bone morphogenetic protein antagonist |
| 02/09/2006 | US20060030056 Use of magnetic material to fractionate samples |
| 02/09/2006 | US20060030055 Methods and kits for separation and detection of proteins in biological samples |
| 02/09/2006 | US20060030053 Methods and systems for protein and peptide evidence assembly |
| 02/09/2006 | US20060030052 Dehydrating gel on which target peptide that has been separated by electrophoresis, immersing in mixture of alkanoic acid anhydride and perfluoroalkanoic acid in dipolar aprotic solvent to re-swell gel carrier; mass spectrometry |
| 02/09/2006 | US20060030051 Erythrocyte sedimentation rate (ESR) test measurement instrument of unitary design and method of using the same |
| 02/09/2006 | US20060030050 Assay |
| 02/09/2006 | US20060030044 Method and composition for skin grafts |
| 02/09/2006 | US20060030033 Label-free high-throughput optical technique for detecting biomolecular interactions |
| 02/09/2006 | US20060030028 Rapid, precise measurement; eliminating peptide interference; covering working electrode with film containing sulfur containing organic compound |
| 02/09/2006 | US20060030019 HDAC9 polypeptides and polynucleotides and uses thereof |
| 02/09/2006 | US20060030018 ultraviolet curable; a free radical photoinitiator, an amine co-initiator and a radiation curable monomer which is a vinyloxyalkyl ester of methacrylic acid; monomers suited for use both in free radically and cationically radiation curable inks |
| 02/09/2006 | US20060030017 Three-dimensional structure of c-Abl |
| 02/09/2006 | US20060030016 Crystal structure of interleukin-2 tyrosine kinase (ITK) and binding pockets thereof |
| 02/09/2006 | US20060030005 C3b/C4b complement receptor-like molecules and uses thereof |
| 02/09/2006 | US20060029998 Codes with nucleic acids; antiinflammatory agents; immunomodulation |
| 02/09/2006 | US20060029993 Analyzing concentration of Matrix Metalloproteinase-9 in a bodily sample comparing this concentration with a reference for concentrations of Matrix Metalloproteinase-9 in individuals who have not suffered a Myocardial Infarction |
| 02/09/2006 | US20060029990 Method for diagnosing inflammatory diseases and infections by the determination of lasp-1 immunoreactivity |
| 02/09/2006 | US20060029989 Targeting cells having Mad2 mutation for treatment and/or prevention of disease |
| 02/09/2006 | US20060029988 Method and compositions for treating diseases targeting E-cadherin |
| 02/09/2006 | US20060029987 Diagnosis of pancreatic cancer by using pancreatic targets |
| 02/09/2006 | US20060029986 Prevention and treatment of cardiovascular pathologies |
| 02/09/2006 | US20060029985 diagnosing the effect of a depression treatment upon a patient suffering from depression, by monitoring the level and function of a blood component selected from a beta-arrestin, a G-protein coupled receptor kinase; administration of a serotonin specific reuptake inhibitor |
| 02/09/2006 | US20060029984 PSP94 diagnostic reagents and assays |
| 02/09/2006 | US20060029983 Methods of screening compounds for GRK6 modulating activity |
| 02/09/2006 | US20060029982 Stable calibrators or controls for measuring human natriuretic peptides |
| 02/09/2006 | US20060029981 monoclonal antibody which specifically binds to an amino acid sequence of islet neogenesis associated protein (INGAP), used in competitive binding assays for quantitation of INGAP in biological samples |
| 02/09/2006 | US20060029980 Method for diagnosing obstructive sleep apnea |
| 02/09/2006 | US20060029979 Electrochemical luminescence composite material with anti-biofouling properties |
| 02/09/2006 | US20060029978 Methods and devices for analyte detection |
| 02/09/2006 | US20060029977 Detection and quantification of prion isoforms in neurodegenerative diseases using mass spectrometry |
| 02/09/2006 | US20060029976 Method for the detection of C-reactive protein in mammalian fluids |
| 02/09/2006 | US20060029971 Determining a gene expression profile from a gene expression product of Homeodomain-containing protein HOXC6; or chromogranin A, platelet-derived growth factor receptor beta, inositol 1, 4, 5-triphosphate receptor type 3, and beta-galactoside alpha-2,6-sialyltransferase; oligonucleotide microarrays |
| 02/09/2006 | US20060029970 Antigen detecting agent and antigen detecting kit, antigen detecting apparatus and antigen detecting method using the same |
| 02/09/2006 | US20060029969 Methods to increase nucleotide signals by Raman scattering |
| 02/09/2006 | US20060029968 Processes for quantitative or qualitative detection of single-stranded or double-stranded nucleic acids |
| 02/09/2006 | US20060029967 Assay for nitrous oxide neurologic syndrome |
| 02/09/2006 | US20060029966 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/09/2006 | US20060029965 System for fluorescence monitoring |
| 02/09/2006 | US20060029964 Eating disorders; measuring obesity receptor (ObR) gene expression by detecting mRNA transcripts |
| 02/09/2006 | US20060029961 Patterned surfaces and their use in diffraction-based sensing |
| 02/09/2006 | US20060029960 Method for the early detection of pancreatic cancer and other gastrointestinal disease conditions |
| 02/09/2006 | US20060029959 Detection method of detecting nucleic acid amplification reaction product and kit for detecting nucleic acid |
| 02/09/2006 | US20060029958 Method for the identification and isolation of strong bacterial promoters |
| 02/09/2006 | US20060029956 Methods and compositions for the detection of ovarian disease |
| 02/09/2006 | US20060029955 High-density ion transport measurement biochip devices and methods |